Evidence map›Paper›PMID 39157603›Full record

ArticleEJHaem2024

Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of

Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto, Haruya Okamoto, Daisuke Ide, Akio Onishi, Daishi Kato, Takahiro Fujino, Yuji Shimira, Aya Miyagawa-Hayashino and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yui Niiyama-UchiboriDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Shinsuke MizutaniDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Taku TsukamotoDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Haruya OkamotoDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Daisuke IdeDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Akio OnishiDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Daishi KatoDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Takahiro FujinoDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Yuji ShimiraDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0001-9309-7902
Aya Miyagawa-HayashinoDepartment of Surgical Pathology Kyoto Prefectural University of Medicine Kyoto Japan.
Eiichi KonishiDepartment of Surgical Pathology Kyoto Prefectural University of Medicine Kyoto Japan.
Kennosuke KarubeDepartment of Pathology and Laboratory Medicine Nagoya University Graduate School of Medicine Nagoya Japan.
Yasuhito NannyaDivision of Hematopoietic Disease Control Institute of Medical Science The University of Tokyo Tokyo Japan.
Junya KurodaDivision of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0001-6130-1550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In ALK-negative anaplastic large cell lymphoma (ALCL), gene rearrangements of

Indexed as

ALK‐negative anaplastic large cell lymphomaDUSP22 gene rearrangementsmall cell patternTBL1XR1‐TP63 inversionTP63 gene rearrangement

Identifiers

PMID39157603
PMCPMC11327721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.